人工呼吸器市場 – 2029年までの世界予測

Report Overview

The ventilators market is projected to reach USD 4.66 Billion by 2029 from USD 3.71 Billion in 2024 at a CAGR of 4.7% during the forecast period.

人工呼吸器市場は、予測期間中に4.7%のCAGRで成長し、2024年の37億1,000万米ドルから2029年には46億6,000万米ドルに達すると予測されています。

Increscent respiratory illnesses like COPD and asthma are key drivers of the ventilators market. With growing air pollution levels, lifestyles, and ageing populations, an increased number of these chronic ailments have resulted in more frequent and severe respiratory attacks. COPD and severe asthma patients frequently need respiratory support through acute exacerbation, increasing hospital and homecare demand for both invasive and non-invasive ventilators. Further, ongoing advancements in ventilator technology—safety, accuracy, and patient outcomes—prompt healthcare professionals to invest in newer respiratory support equipment. In sum, the increasing burden of respiratory illnesses is driving market growth.

COPD や喘息などの呼吸器疾患の増加は、人工呼吸器市場の主要な推進力です。大気汚染レベル、ライフスタイル、人口の高齢化が進む中、これらの慢性疾患の増加により、呼吸器発作の頻度と重症度が増しています。COPD や重度の喘息患者は、急性増悪時に呼吸補助を必要とすることが多く、侵襲性人工呼吸器と非侵襲性人工呼吸器の両方に対する病院および在宅ケアの需要が高まっています。さらに、人工呼吸器技術 (安全性、精度、患者の転帰) の継続的な進歩により、医療従事者は新しい呼吸補助装置に投資するようになっています。つまり、呼吸器疾患の負担増加が市場の成長を牽引しているのです。

“The High-end ICU ventilators segment is accounted for the largest share of  global ventilators market.”

Premium ICU ventilators have the largest market share of the worldwide ventilators market due to the fact that they are essential in the treatment of life-threatening situations in intensive care units. Such high-end equipment has a comprehensive variety of ventilation modes, advanced monitoring systems, and improved safety features that are necessary for critical patients. With the aging worldwide population and prevalence of sophisticated respiratory diseases, healthcare facilities are aggressively investing in next-generation ICU solutions. In addition, ongoing development and strict standards imposed by regulative bodies support the use of these advanced devices, making them the go-to option in life-critical applications where the utmost patient outcomes must be achieved.

“Combined mode ventilation has the largest market share in ventilators market.”

Combined mode ventilators command the highest market share in the ventilators segment due to the fact that they provide the most advantageous aspects of volume- and pressure-controlled ventilation, allowing clinicians to customize respiratory support to the individual needs of a patient. The products allow clinicians to accurately control tidal volumes while also limiting pressure so that the lungs are not injured, thereby giving a versatile solution that can work in a number of clinical circumstances. Their paired, high-tech monitoring systems and automated adjustments do not only add convenience but also improve patient results. Accordingly, combined mode ventilators are in great demand among intensive care units with critically ill patients who need dynamic and flexible modes of ventilation. In addition, unbroken technology innovation, increased spending on healthcare facilities, and increasing instances of respiratory diseases have each played a role to drive combined mode ventilators to the top of the market.

“Europe holds the second largest market share in the ventilators market.”

Europe is the world’s second-largest ventilator market, with its established healthcare infrastructure, heavy government spending, and stringent regulation that guarantees top-quality products. Extensive coverage of intensive care units and hospitals in Europe, combined with high incidence of respiratory conditions and the ageing population, all ensure rising demand for invasive as well as non-invasive ventilators.

Moreover, Europe is favored with a vibrant community of top-notch producers and never-ending innovation, leading to the development of ultra-modern technologies that improve patient results. Together with forward-looking healthcare measures and all-encompassing insurance coverage, Europe is a strong market for ventilators worldwide, guaranteeing its position as the second largest market share holder.

A breakdown of the primary participants (supply-side) for the ventilators market referred to for this report is provided below:

• By Company Type: Tier 1–25%, Tier 2–40%, and Tier 3–35%
• By Designation: C-level–20%, Director Level–38%, and Others–40%
• By Region: North America–37%, Europe–28%, Asia Pacific–26%, Latin America- 6%, and Middle East and Africa– 1% and GCC Countries– 2%

Prominent players in this market include ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Drägerwerk AG & CO. KGAA (Germany), ICU Medical, Inc. (US), Asahi Kasei Corporation (Japan), Air Liquide (France), Flexicare (Group) Limited (UK), Nihon Kohden Corporation (Japan), Shenzhen Mindray Bio-Medical Electronics Co., Ltd, (China), GE Healthcare (US), Baxter (US), Vyaire Medical, Inc. (US), Hamilton Medical (Switzerland), Skanray Technologies (India), aXcent Medical GmbH (Germany), Metran Co., Ltd (Japan), MAGNAMED (Brazil), Leistung Ingeniería SRL (Argentina), Avasarala Technologies Limited (India), Airon Corporation (Florida), TRITON Electronic Systems Ltd. (Russia), Bio-Med Devices, Inc. (US), HEYER Medical AG (Germany) and AgVa Healthcare (India).

Research Coverage:

The market study covers the ventilators market across various segments. It aims at estimating the market size and the growth potential of this market across different segments by type, age group, interface, mode, care setting and region. The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share of the market. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their positions in the market.

This report provides insights on:

Analysis of Market Dynamics: Drivers (Rise in respiratory diseases

Urbanization and rising pollution levels, Rising obesity due to sedentary lifestyles, Growing geriatric population worldwide,  Increasing preference for home care settings, Rising number of preterm births, Outbreak of infectious respiratory diseases) restraints (Shortage of skilled medical workers, Excessive purchase of ventilators during COVID-19, Reimbursement concerns) opportunities (Cost-efficiency of home care services, growth opportunities in emerging economies), and challenges (Low awareness and inadequate resources in emerging economies, Harmful effects of respiratory devices on neonates, Supply chain disruptions, Global demand fluctuations)

• Services/Innovations: Detailed insights on upcoming technologies, research & development activities, and new product launches in the ventilators market.
• Market Development: Comprehensive information on the lucrative emerging markets, components, demographics, care settings, and region.
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the ventilators market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the ventilators market like ResMed (US), Getinge AB (Sweden), Koninklijke Philips N.V. (Netherlands), Drägerwerk AG & CO. KGAA (Germany), and ICU Medical, Inc. (US).

Table of Contents

1               INTRODUCTION              25

1.1           STUDY OBJECTIVES       25

1.2           MARKET DEFINITION   25

1.3           STUDY SCOPE   26

1.3.1        MARKETS COVERED & REGIONS CONSIDERED  26

1.3.2        INCLUSIONS AND EXCLUSIONS 27

1.3.3        YEARS CONSIDERED      28

1.3.4        CURRENCY CONSIDERED            28

1.4           STAKEHOLDERS               29

1.5           SUMMARY OF CHANGES               29

1.6           IMPACT OF AI/GEN AI   30

2               RESEARCH METHODOLOGY       31

2.1           RESEARCH DATA              31

2.1.1        SECONDARY RESEARCH                32

2.1.1.1    Key data from secondary sources       33

2.1.2        PRIMARY RESEARCH       33

2.1.2.1    Key data from primary sources           34

2.1.2.2    Key industry insights           35

2.2           MARKET SIZE ESTIMATION         37

2.3           MARKET BREAKDOWN AND DATA TRIANGULATION                 43

2.4           RESEARCH ASSUMPTIONS           44

2.5           RESEARCH LIMITATIONS             45

2.5.1        SCOPE-RELATED LIMITATIONS                 45

2.5.2        METHODOLOGY-RELATED LIMITATIONS           45

2.6           RISK ASSESSMENT           45

3               EXECUTIVE SUMMARY  46

4               PREMIUM INSIGHTS       50

4.1           VENTILATORS MARKET OVERVIEW        50

4.2           ASIA PACIFIC: VENTILATORS MARKET, BY TYPE AND COUNTRY (2024)               51

4.3           VENTILATORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              52

4.4           VENTILATORS MARKET: REGIONAL MIX               52

4.5           VENTILATORS MARKET: DEVELOPED MARKETS VS. EMERGING ECONOMIES               53

5               MARKET OVERVIEW       54

5.1           INTRODUCTION              54

5.2           MARKET DYNAMICS       54

5.2.1        DRIVERS               55

5.2.1.1    Rise in respiratory diseases 55

5.2.1.1.1 Increasing incidences of COPD and asthma   55

5.2.1.1.2 High prevalence of tobacco smoking 55

5.2.1.2    Urbanization and rising pollution levels           56

5.2.1.3    Rising obesity due to sedentary lifestyles          57

5.2.1.4    Growing geriatric population worldwide          57

5.2.1.5    Increasing preference for home care settings  58

5.2.1.6    Rising number of preterm births       58

5.2.1.7    Outbreak of infectious respiratory diseases     59

5.2.2        RESTRAINTS      59

5.2.2.1    Shortage of skilled medical workers  59

5.2.2.2    Excessive purchase of ventilators during COVID-19     59

5.2.2.3    Reimbursement concerns    60

5.2.3        OPPORTUNITIES              60

5.2.3.1    Cost-efficiency of home care services                60

5.2.3.2    Growth opportunities in emerging economies 61

5.2.4        CHALLENGES    61

5.2.4.1    Low awareness and inadequate resources in emerging economies                 61

5.2.4.2    Harmful effects of respiratory devices on neonates         61

5.2.4.3    Supply chain disruptions     62

5.2.4.4    Global demand fluctuations                62

5.3           INDUSTRY TRENDS         63

5.3.1        RISING DEMAND FOR ENHANCED PORTABLE VENTILATORS  63

5.3.2        MARKET CONSOLIDATION         64

5.3.3        GROWING DEMAND FOR MULTIMODAL VENTILATORS                 64

5.3.4        INCREASING ADOPTION OF NON-INVASIVE VENTILATORS  65

5.4           TECHNOLOGY ANALYSIS             65

5.4.1        KEY TECHNOLOGIES     66

5.4.1.1    Sensor technologies              66

5.4.1.1.1 Flow sensors          66

5.4.1.1.2 Oxygen sensors     66

5.4.1.1.3 Pressure sensors   67

5.4.2        COMPLEMENTARY TECHNOLOGIES       67

5.4.2.1    E-nose technology                67

5.4.2.2    MEMS technology                68

5.4.2.3    Electrochemical technology                 68

5.4.2.4    Paramagnetic technology    68

5.4.2.5    Wireless gas sensor technology           68

5.4.3        ADJACENT TECHNOLOGIES       69

5.4.3.1    High-flow nasal cannula (HFNC) devices        69

5.5           PRICING ANALYSIS          69

5.5.1        INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER 69

5.5.2        AVERAGE SELLING PRICE TREND, BY REGION   70

5.6           VALUE CHAIN ANALYSIS               71

5.7           ECOSYSTEM ANALYSIS  72

5.8           SUPPLY CHAIN ANALYSIS             74

5.9           PORTER’S FIVE FORCES ANALYSIS           76

5.9.1        THREAT OF NEW ENTRANTS      77

5.9.2        THREAT OF SUBSTITUTES          77

5.9.3        BARGAINING POWER OF SUPPLIERS       77

5.9.4        BARGAINING POWER OF BUYERS             77

5.9.5        INTENSITY OF COMPETITIVE RIVALRY 78

5.10         KEY STAKEHOLDERS AND BUYING CRITERIA     78

5.10.1      KEY STAKEHOLDERS IN BUYING PROCESS           78

5.10.2      BUYING CRITERIA           80

5.11         REGULATORY ANALYSIS               81

5.11.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             81

5.11.2      REGULATORY FRAMEWORK       83

5.11.2.1  North America      83

5.11.2.1.1                US           83

5.11.2.1.2                Canada   83

5.11.2.2  Europe   83

5.11.2.3  Asia Pacific            84

5.11.2.3.1                Japan      84

5.11.2.3.2                China      84

5.11.2.3.3                India       84

5.11.2.3.4                South Korea           84

5.11.2.4  Latin America       85

5.11.2.4.1                Brazil      85

5.11.2.4.2                Mexico   85

5.11.2.5  Middle East           86

5.11.2.6  Africa      86

5.12         PATENT ANALYSIS          86

5.12.1      PATENT PUBLICATION TRENDS FOR VENTILATORS                 86

5.13         TRADE ANALYSIS             89

5.13.1      EXPORT DATA FOR VENTILATORS (HS CODE 9018)                 90

5.13.2      IMPORT DATA FOR VENTILATORS (HS CODE 9018)                 91

5.14         KEY CONFERENCES AND EVENTS, 2023–2024        91

5.15         REIMBURSEMENT SCENARIO     92

5.16         UNMET NEEDS AND END-USER EXPECTATIONS                 93

5.16.1      UNMET NEEDS IN VENTILATORS MARKET           93

5.16.2      END-USER EXPECTATIONS IN VENTILATORS MARKET                 94

5.17         TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES       95

5.18         INVESTMENT & FUNDING SCENARIO     95

5.19         ADJACENT MARKET ANALYSIS  97

5.19.1      RESPIRATORY DIAGNOSTICS MARKET  97

5.19.2      SLEEP APNEA DEVICES MARKET               98

5.20         IMPACT OF AI/GEN AI ON VENTILATORS MARKET                 98

5.20.1      INTRODUCTION              98

5.20.2      FUTURE OF HEALTHCARE—BIG DATA AND AI  99

5.20.3      KNOWLEDGE-BASED SYSTEMS FOR VENTILATION MANAGEMENT 99

6               VENTILATORS MARKET, BY TYPE             102

6.1           INTRODUCTION              103

6.2           INTENSIVE CARE VENTILATORS               103

6.2.1        HIGH-END ICU VENTILATORS   106

6.2.1.1    Rising healthcare expenditure and improving infrastructure in emerging economies to drive market 106

6.2.2        MID-END ICU VENTILATORS      108

6.2.2.1    Higher affordability and accessibility to drive market    108

6.2.3        BASIC ICU VENTILATORS             110

6.2.3.1    Growing use in ambulatory care centers to drive market                 110

6.3           PORTABLE/TRANSPORTABLE VENTILATORS     112

6.3.1        INCREASING DEMAND FOR COMPACT DEVICES FOR MECHANICAL VENTILATION TO DRIVE MARKET              112

7               VENTILATORS MARKET, BY AGE GROUP               114

7.1           INTRODUCTION              115

7.2           ADULT & PEDIATRIC VENTILATORS       115

7.2.1        GROWING GERIATRIC POPULATION TO DRIVE MARKET                 115

7.3           NEONATAL/INFANT VENTILATORS        117

7.3.1        TECHNOLOGICAL ADVANCEMENTS IN NEONATAL MONITORS TO DRIVE MARKET 117

8               VENTILATION MARKET, BY INTERFACE                119

8.1           INTRODUCTION              120

8.2           HYBRID VENTILATION 120

8.2.1        RISING PREVALENCE OF COPD & ARDS TO DRIVE MARKET               120

8.3           NON-INVASIVE VENTILATION   121

8.3.1        RELIABILITY OF MECHANICAL DESIGNS TO DRIVE MARKET               121

8.4           INVASIVE VENTILATION               123

8.4.1        RISING PREVALENCE OF RESPIRATORY DISEASES TO DRIVE MARKET 123

9               VENTILATORS MARKET, BY MODE          124

9.1           INTRODUCTION              125

9.2           COMBINED-MODE VENTILATORS            125

9.2.1        COMBINED BENEFITS OF VOLUME-TARGETED AND PRESSURE-TARGETED VENTILATORS TO DRIVE MARKET                 125

9.3           VOLUME-MODE VENTILATORS 126

9.3.1        INCREASING DEMAND FOR ADVANCED RESPIRATORY SUPPORT SYSTEMS IN HEALTHCARE SETTINGS TO DRIVE MARKET               126

9.4           PRESSURE-MODE VENTILATORS              128

9.4.1        PRESET INSPIRATORY PRESSURE MAINTENANCE AND BETTER PATIENT COMFORT TO DRIVE MARKET              128

9.5           OTHER VENTILATORS  129

10            VENTILATORS MARKET, BY CARE SETTING         131

10.1         INTRODUCTION              132

10.2         HOSPITALS & CLINICS   132

10.2.1      RISING DEMAND FOR VENTILATORS IN PRIVATE HOSPITALS TO DRIVE MARKET 132

10.3         AMBULATORY CARE CENTERS  133

10.3.1      INCREASING NUMBER OF OUTPATIENT VISITS TO DRIVE MARKET 133

10.4         EMERGENCY MEDICAL SERVICES             135

10.4.1      HIGH INCIDENCE OF TRAUMA INJURIES TO DRIVE MARKET               135

10.5         HOME CARE SETTINGS 136

10.5.1      EMERGENCE OF REMOTE PATIENT MONITORING DEVICES TO DRIVE MARKET      136

11            VENTILATORS MARKET, BY REGION       138

11.1         INTRODUCTION              139

11.2         NORTH AMERICA             139

11.2.1      MACROECONOMIC OUTLOOK FOR NORTH AMERICA                 140

11.2.2      US           144

11.2.2.1  High prevalence of COPD to drive the market                144

11.2.3      CANADA               146

11.2.3.1  Increasing incidence of asthma to drive market               146

11.3         EUROPE               149

11.3.1      MACROECONOMIC OUTLOOK FOR EUROPE      150

11.3.2      GERMANY           153

11.3.2.1  Rising healthcare spending to increase demand for high-end ventilators              153

11.3.3      FRANCE                156

11.3.3.1  Highly advanced healthcare system to drive adoption of ventilators in hospitals         156

11.3.4      UK          158

11.3.4.1  Increasing healthcare expenditure to drive market growth                 158

11.3.5      ITALY    161

11.3.5.1  High growth in geriatric population and subsequent rise in age-related respiratory diseases to drive market     161

11.3.6      SPAIN    164

11.3.6.1  High burden on state-run health insurance system and poor healthcare infrastructure to restrain market growth       164

11.3.7      NETHERLANDS 167

11.3.7.1  Rising prevalence of respiratory diseases to drive market                 167

11.3.8      REST OF EUROPE             169

11.4         ASIA PACIFIC     172

11.4.1      MACROECONOMIC OUTLOOK FOR ASIA PACIFIC                 172

11.4.2      JAPAN   177

11.4.2.1  Established healthcare system to increase adoption of respiratory care devices           177

11.4.3      CHINA  180

11.4.3.1  High prevalence of COPD and lung cancer to propel demand                 180

11.4.4      INDIA    183

11.4.4.1  Rising focus of global players on the Indian market to drive adoption of advanced ventilators       183

11.4.5      AUSTRALIA         185

11.4.5.1  High prevalence of chronic lung diseases to drive demand for ventilators              185

11.4.6      REST OF ASIA PACIFIC   188

11.5         LATIN AMERICA                190

11.5.1      MACROECONOMIC OUTLOOK FOR LATIN AMERICA                 191

11.5.2      BRAZIL 193

11.5.2.1  Healthcare infrastructure improvement to support market growth    193

11.5.3      MEXICO                196

11.5.3.1  Rising obesity rate to increase incidence rate of respiratory diseases  196

11.5.4      ARGENTINA       199

11.5.4.1  Incidence of severe acute respiratory infections to drive market                 199

11.5.5      REST OF LATIN AMERICA             201

11.6         MIDDLE EAST & AFRICA                204

11.6.1      RISING HEALTHCARE SPENDING AND PRESENCE OF MEDICAL DEVICE MANUFACTURING COMPANIES TO DRIVE MARKET               204

11.6.2      MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 204

11.7         GCC COUNTRIES              206

11.7.1      HIGHER DISPOSABLE INCOME AND INCREASED GOVERNMENT HEALTHCARE EXPENDITURE TO PROPEL MARKET GROWTH          206

11.7.2      MACROECONOMIC OUTLOOK FOR GCC COUNTRIES                 207

12            COMPETITIVE LANDSCAPE         210

12.1         OVERVIEW          210

12.2         KEY PLAYER STRATEGIES/RIGHT TO WIN 2023  210

12.2.1      OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN VENTILATORS MARKET                210

12.3         REVENUE ANALYSIS, 2019–2023  211

12.4         MARKET SHARE ANALYSIS, 2023                 212

12.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 214

12.5.1      STARS   214

12.5.2      EMERGING LEADERS     214

12.5.3      PERVASIVE PLAYERS      214

12.5.4      PARTICIPANTS 214

12.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         215

12.5.5.1  Company footprint               216

12.5.5.2  Region footprint   217

12.5.5.3  Type footprint       218

12.5.5.4  Age group footprint              219

12.5.5.5  Interface footprint                 220

12.5.5.6  Mode footprint      221

12.5.5.7  Care setting footprint           222

12.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        223

12.6.1      PROGRESSIVE COMPANIES         223

12.6.2      RESPONSIVE COMPANIES            223

12.6.3      DYNAMIC COMPANIES  223

12.6.4      STARTING BLOCKS         223

12.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 225

12.6.5.1  Detailed list of key startups/SMEs    225

12.6.5.2  Competitive benchmarking of key startups/SMEs          225

12.7         VENTILATORS MARKET: R&D EXPENDITURE     226

12.8         COMPANY VALUATION & FINANCIAL METRICS 227

12.8.1      FINANCIAL METRICS      227

12.8.2      COMPANY VALUATION 227

12.9         BRAND/PRODUCT COMPARISON             228

12.10       COMPETITIVE SCENARIO             229

12.10.1   PRODUCT LAUNCHES & APPROVALS     229

12.10.2   DEALS  230

12.10.3   OTHER DEVELOPMENTS              231

13            COMPANY PROFILES      232

13.1         KEY PLAYERS     232

13.1.1      RESMED               232

13.1.1.1  Business overview 232

13.1.1.2  Products offered   233

13.1.1.3  Recent developments           234

13.1.1.3.1                Product launches & approvals            234

13.1.1.4  MnM view              234

13.1.1.4.1                Right to win           234

13.1.1.4.2                Strategic choices   234

13.1.1.4.3                Weaknesses and competitive threats 234

13.1.2      GETINGE AB      235

13.1.2.1  Business overview 235

13.1.2.2  Products offered   236

13.1.2.3  Recent developments           237

13.1.2.3.1                Product launches & approvals            237

13.1.2.3.2                Other developments             237

13.1.2.4  MnM view              237

13.1.2.4.1                Right to win           237

13.1.2.4.2                Strategic choices   238

13.1.2.4.3                Weaknesses and competitive threats 238

13.1.3      KONINKLIJKE PHILIPS N.V.          239

13.1.3.1  Business overview 239

13.1.3.2  Products offered   240

13.1.3.3  Recent developments           241

13.1.3.3.1                Other developments             241

13.1.3.4  MnM view              241

13.1.3.4.1                Right to win           241

13.1.3.4.2                Strategic choices   241

13.1.3.4.3                Weaknesses and competitive threats 242

13.1.4      DRÄGERWERK AG & CO. KGAA  243

13.1.4.1  Business overview 243

13.1.4.2  Products offered   244

13.1.4.3  Recent developments           245

13.1.4.3.1                Product launches & approvals            245

13.1.4.3.2                Deals      245

13.1.4.3.3                Other developments             246

13.1.5      ICU MEDICAL INC.           247

13.1.5.1  Business overview 247

13.1.5.2  Products offered   248

13.1.5.3  Recent developments           249

13.1.5.3.1                Deals      249

13.1.6      ASAHI KASEI CORPORATION      250

13.1.6.1  Business overview 250

13.1.6.2  Products offered   252

13.1.6.3  Recent developments           253

13.1.6.3.1                Deals      253

13.1.7      AIR LIQUIDE      254

13.1.7.1  Business overview 254

13.1.7.2  Products offered   255

13.1.7.3  Recent developments           256

13.1.7.3.1                Deals      256

13.1.8      FLEXICARE (GROUP) LIMITED  257

13.1.8.1  Business overview 257

13.1.8.2  Products offered   258

13.1.8.3  Recent developments           258

13.1.8.3.1                Deals      258

13.1.9      NIHON KOHDEN CORPORATION              259

13.1.9.1  Business overview 259

13.1.9.2  Products offered   260

13.1.9.3  Recent developments           261

13.1.9.3.1                Product launches  261

13.1.10   SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.      262

13.1.10.1                 Business overview 262

13.1.10.2                 Products offered   263

13.1.11   GE HEALTHCARE             264

13.1.11.1                 Business overview 264

13.1.11.2                 Products offered   265

13.1.11.3                 Recent developments           265

13.1.11.3.1             Deals      265

13.1.12   BAXTER                266

13.1.12.1                 Business overview 266

13.1.12.2                 Products offered   267

13.1.12.3                 Recent developments           268

13.1.12.3.1             Deals      268

13.1.13   VYAIRE MEDICAL, INC.  269

13.1.13.1                 Business overview 269

13.1.13.2                 Products offered   269

13.1.13.3                 Recent developments           270

13.1.13.3.1             Deals      270

13.1.13.3.2             Other developments             270

13.1.14   HAMILTON MEDICAL    271

13.1.14.1                 Business overview 271

13.1.14.2                 Products offered   271

13.1.14.3                 Recent developments           272

13.1.14.3.1             Product enhancements        272

13.2         OTHER PLAYERS              273

13.2.1      SKANRAY TECHNOLOGIES, LTD.               273

13.2.2      AXCENT MEDICAL GMBH             274

13.2.3      METRAN CO., LTD.          275

13.2.4      MAGNAMED      276

13.2.5      LEISTUNG INGENIERÍA SRL         277

13.2.6      AVASARALA TECHNOLOGIES LIMITED 277

13.2.7      AIRON CORPORATION  278

13.2.8      TRITON ELECTRONIC SYSTEMS LTD.     278

13.2.9      BIO-MED DEVICES, INC.                279

13.2.10   HEYER MEDICAL AG       279

13.2.11   AGVA HEALTHCARE       280

13.2.12   BIODESIGN INNOVATION LABS                 280

13.2.13   NOCCARC ROBOTICS PVT LTD 281

13.2.14   UMBULIZER       281

13.2.15   SCHILLER HEALTHCARE INDIA PVT. LTD             282

13.2.16   AVI HEALTHCARE            282

14            APPENDIX           283

14.1         DISCUSSION GUIDE        283

14.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                288

14.3         CUSTOMIZATION OPTIONS        290

14.4         RELATED REPORTS         290

14.5         AUTHOR DETAILS           291

LIST OF TABLES

TABLE 1                STANDARD CURRENCY CONVERSION RATES                 28

TABLE 2                RISK ASSESSMENT           45

TABLE 3                DISORDERS AND DEATHS CAUSED DUE TO SMOKING, 2024 56

TABLE 4                INDUSTRY TRENDS IN VENTILATORS MARKET                 63

TABLE 5                INDICATIVE PRICING OF VENTILATORS, BY KEY PLAYER, 2024 (USD)        69

TABLE 6                AVERAGE SELLING PRICE TREND OF HIGH-END VENTILATORS, BY REGION,

2022–2024 (USD)                70

TABLE 7                VENTILATORS MARKET: ECOSYSTEM ANALYSIS                 73

TABLE 8                VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS           76

TABLE 9                KEY STAKEHOLDERS IN BUYING PROCESS                 78

TABLE 10              INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS     80

TABLE 11              KEY BUYING CRITERIA FOR VENTILATORS                 80

TABLE 12              NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  81

TABLE 13              EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  81

TABLE 14              ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  82

TABLE 15              LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  82

TABLE 16              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS 83

TABLE 17              LIST OF PATENTS IN VENTILATORS MARKET (2025)    88

TABLE 18              TRADE ANALYSIS OF MEDICAL DEVICE PRODUCTS, 2023 (USD MILLION)              90

TABLE 19              EXPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND)          90

TABLE 20              IMPORT DATA FOR VENTILATORS (HS CODE 9018), 2019-2023 (USD THOUSAND)          91

TABLE 21              VENTILATORS MARKET: KEY CONFERENCES AND EVENTS, 2023–2024                 91

TABLE 22              REIMBURSEMENT SCENARIO IN VENTILATORS MARKET               93

TABLE 23              UNMET NEEDS IN VENTILATORS MARKET                 93

TABLE 24              END-USER EXPECTATIONS IN VENTILATORS MARKET               94

TABLE 25              VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 103

TABLE 26              INTENSIVE CARE VENTILATORS: KEY PRODUCTS         104

TABLE 27              INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)                105

TABLE 28              INTENSIVE CARE VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            105

TABLE 29              INTENSIVE CARE VENTILATORS MARKET, BY REGION,

2021–2029 (THOUSAND UNITS)  106

TABLE 30              HIGH-END ICU VENTILATORS: KEY PRODUCTS                 106

TABLE 31              HIGH-END ICU VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     107

TABLE 32              HIGH-END ICU VENTILATORS MARKET, BY REGION,

2021–2029 (THOUSAND UNITS)  107

TABLE 33              MID-END ICU VENTILATORS: KEY PRODUCTS                 108

TABLE 34              MID-END ICU VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     109

TABLE 35              MID-END ICU VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS)                109

TABLE 36              BASIC ICU VENTILATORS: KEY PRODUCTS                 110

TABLE 37              BASIC ICU VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     111

TABLE 38              BASIC ICU VENTILATORS MARKET, BY REGION, 2021–2029 (THOUSAND UNITS)  111

TABLE 39              PORTABLE/TRANSPORTABLE VENTILATORS: KEY PRODUCTS                112

TABLE 40              PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            113

TABLE 41              PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION,

2021–2029 (THOUSAND UNITS)  113

TABLE 42              VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)       115

TABLE 43              ADULT & PEDIATRIC VENTILATORS: KEY PRODUCTS         116

TABLE 44              ADULT & PEDIATRIC VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            116

TABLE 45              NEONATAL/INFANT VENTILATORS: KEY PRODUCTS         117

TABLE 46              NEONATAL/INFANT VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            118

TABLE 47              VENTILATION MARKET, BY INTERFACE, 2021–2029 (USD MILLION)       120

TABLE 48              HYBRID VENTILATION MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            121

TABLE 49              NON-INVASIVE VENTILATION MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     122

TABLE 50              INVASIVE VENTILATION MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     123

TABLE 51              VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION) 125

TABLE 52              COMBINED-MODE VENTILATORS: KEY PRODUCTS         125

TABLE 53              COMBINED-MODE VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            126

TABLE 54              VOLUME-MODE VENTILATORS: KEY PRODUCTS         127

TABLE 55              VOLUME-MODE VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     127

TABLE 56              PRESSURE-MODE VENTILATORS: KEY PRODUCTS         128

TABLE 57              PRESSURE-MODE VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            129

TABLE 58              OTHER VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            130

TABLE 59              VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)            132

TABLE 60              VENTILATORS MARKET FOR HOSPITALS & CLINICS, BY COUNTRY,

2021–2029 (USD MILLION)            133

TABLE 61              VENTILATORS MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY,

2021–2029 (USD MILLION)            134

TABLE 62              VENTILATORS MARKET FOR EMERGENCY MEDICAL SERVICES, BY COUNTRY, 2021–2029 (USD MILLION)                 135

TABLE 63              VENTILATORS MARKET FOR HOME CARE SETTINGS, BY COUNTRY,

2021–2029 (USD MILLION)            137

TABLE 64              VENTILATORS MARKET, BY REGION, 2021–2029 (USD MILLION) 139

TABLE 65              NORTH AMERICA: VENTILATORS MARKET, BY COUNTRY,

2021–2029 (USD MILLION)            141

TABLE 66              NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)                142

TABLE 67              NORTH AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            142

TABLE 68              NORTH AMERICA: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            142

TABLE 69              NORTH AMERICA: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            143

TABLE 70              NORTH AMERICA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)             143

TABLE 71              NORTH AMERICA: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            143

TABLE 72              US: KEY MACROINDICATORS FOR VENTILATORS MARKET                144

TABLE 73              US: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 144

TABLE 74              US: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)         145

TABLE 75              US: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            145

TABLE 76              US: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            145

TABLE 77              US: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)       146

TABLE 78              US: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)            146

TABLE 79              CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)               147

TABLE 80              CANADA: KEY MACROINDICATORS FOR VENTILATORS MARKET                147

TABLE 81              CANADA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            147

TABLE 82              CANADA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            148

TABLE 83              CANADA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           148

TABLE 84              CANADA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  148

TABLE 85              CANADA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            149

TABLE 86              CANADA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        149

TABLE 87             EUROPE: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)            151

TABLE 88              EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            151

TABLE 89              EUROPE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            151

TABLE 90              EUROPE: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           152

TABLE 91              EUROPE: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  152

TABLE 92              EUROPE: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            152

TABLE 93              EUROPE: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        153

TABLE 94              GERMANY: KEY MACROINDICATORS FOR VENTILATORS MARKET                153

TABLE 95              GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            154

TABLE 96              GERMANY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            154

TABLE 97              GERMANY: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           154

TABLE 98              GERMANY: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  155

TABLE 99              GERMANY: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            155

TABLE 100            GERMANY: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        155

TABLE 101            FRANCE: KEY MACROINDICATORS FOR VENTILATORS MARKET                156

TABLE 102            FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            156

TABLE 103            FRANCE: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            157

TABLE 104            FRANCE: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           157

TABLE 105            FRANCE: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  157

TABLE 106            FRANCE: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            158

TABLE 107            FRANCE: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        158

TABLE 108            UK: KEY MACROINDICATORS FOR VENTILATORS MARKET                159

TABLE 109            UK: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION) 159

TABLE 110            UK: INTENSIVE CARE VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)         160

TABLE 111            UK: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            160

TABLE 112            UK: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            160

TABLE 113            UK: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)       161

TABLE 114            UK: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)            161

TABLE 115            ITALY: KEY MACROINDICATORS FOR VENTILATORS MARKET                162

TABLE 116            ITALY: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)       162

TABLE 117            ITALY: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            162

TABLE 118            ITALY: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            163

TABLE 119            ITALY: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            163

TABLE 120            ITALY: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)       163

TABLE 121            ITALY: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        164

TABLE 122            SPAIN: KEY MACROINDICATORS FOR VENTILATORS MARKET                164

TABLE 123            SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)       165

TABLE 124            SPAIN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            165

TABLE 125            SPAIN: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            165

TABLE 126            SPAIN: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            166

TABLE 127            SPAIN: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)       166

TABLE 128            SPAIN: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        166

TABLE 129            NETHERLANDS: KEY MACROINDICATORS FOR VENTILATORS MARKET                167

TABLE 130            NETHERLANDS: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)                167

TABLE 131            NETHERLANDS: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            168

TABLE 132            NETHERLANDS: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            168

TABLE 133            NETHERLANDS: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            168

TABLE 134            NETHERLANDS: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)             169

TABLE 135            NETHERLANDS: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            169

TABLE 136            REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)                170

TABLE 137            REST OF EUROPE: INTENSIVE CARE VENTILATORS MARKET,

BY TYPE, 2021–2029 (USD MILLION)         170

TABLE 138            REST OF EUROPE: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            170

TABLE 139            REST OF EUROPE: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            171

TABLE 140            REST OF EUROPE: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)             171

TABLE 141            REST OF EUROPE: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            171

TABLE 142            ASIA PACIFIC: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     175

TABLE 143            ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            175

TABLE 144            ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            175

TABLE 145            ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           176

TABLE 146            ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  176

TABLE 147            ASIA PACIFIC: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)             176

TABLE 148            ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            177

TABLE 149            JAPAN: KEY MACROINDICATORS FOR VENTILATORS MARKET                178

TABLE 150            JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)       178

TABLE 151            JAPAN: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            178

TABLE 152            JAPAN: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            179

TABLE 153            JAPAN: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            179

TABLE 154            JAPAN: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)       179

TABLE 155            JAPAN: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        180

TABLE 156            CHINA: KEY MACROINDICATORS FOR VENTILATORS MARKET                180

TABLE 157            CHINA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)       181

TABLE 158            CHINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            181

TABLE 159          CHINA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            181

TABLE 160            CHINA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            182

TABLE 161            CHINA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION).           182

TABLE 162            CHINA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        182

TABLE 163            INDIA: KEY MACROINDICATORS FOR VENTILATORS MARKET                183

TABLE 164            INDIA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)       183

TABLE 165            INDIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            184

TABLE 166            INDIA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)            184

TABLE 167            INDIA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            184

TABLE 168            INDIA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)       185

TABLE 169            INDIA: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        185

TABLE 170            AUSTRALIA: KEY MACROINDICATORS FOR VENTILATORS MARKET                186

TABLE 171            AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            186

TABLE 172            AUSTRALIA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            186

TABLE 173            AUSTRALIA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           187

TABLE 174            AUSTRALIA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  187

TABLE 175            AUSTRALIA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            187

TABLE 176            AUSTRALIA: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            188

TABLE 177            REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            188

TABLE 178            REST OF ASIA PACIFIC: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            189

TABLE 179            REST OF ASIA PACIFIC: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            189

TABLE 180            REST OF ASIA PACIFIC: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            189

TABLE 181            REST OF ASIA PACIFIC: VENTILATORS MARKET, BY MODE,

2021–2029 (USD MILLION)            190

TABLE 182            REST OF ASIA PACIFIC: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            190

TABLE 183            LATIN AMERICA: VENTILATORS MARKET, BY COUNTRY, 2021–2029 (USD MILLION)     191

TABLE 184            LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)                191

TABLE 185            LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            192

TABLE 186            LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            192

TABLE 187            LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            192

TABLE 188            LATIN AMERICA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)             193

TABLE 189            LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            193

TABLE 190            BRAZIL: KEY MACROINDICATORS FOR VENTILATORS MARKET                194

TABLE 191            BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)       194

TABLE 192            BRAZIL: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            194

TABLE 193            BRAZIL: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           195

TABLE 194          BRAZIL: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)            195

TABLE 195            BRAZIL: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            195

TABLE 196            BRAZIL: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        196

TABLE 197            MEXICO: KEY MACROINDICATORS FOR VENTILATORS MARKET                196

TABLE 198            MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            197

TABLE 199            MEXICO: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            197

TABLE 200            MEXICO: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           197

TABLE 201            MEXICO: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  198

TABLE 202            MEXICO: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            198

TABLE 203            MEXICO: VENTILATORS MARKET, BY CARE SETTING, 2021–2029 (USD MILLION)        198

TABLE 204            ARGENTINA: KEY MACROINDICATORS FOR VENTILATORS MARKET                199

TABLE 205            ARGENTINA: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)            199

TABLE 206            ARGENTINA: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            200

TABLE 207            ARGENTINA: VENTILATORS MARKET, BY AGE GROUP, 2021–2029 (USD MILLION)           200

TABLE 208            ARGENTINA: VENTILATORS MARKET, BY INTERFACE, 2021–2029 (USD MILLION)  200

TABLE 209          ARGENTINA: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)            201

TABLE 210            ARGENTINA: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            201

TABLE 211            REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            202

TABLE 212            REST OF LATIN AMERICA: INTENSIVE CARE VENTILATORS MARKET,

BY TYPE, 2021–2029 (USD MILLION)         202

TABLE 213            REST OF LATIN AMERICA: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            202

TABLE 214            REST OF LATIN AMERICA: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            203

TABLE 215            REST OF LATIN AMERICA: VENTILATORS MARKET, BY MODE,

2021–2029 (USD MILLION)            203

TABLE 216            REST OF LATIN AMERICA: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            203

TABLE 217            MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            204

TABLE 218            MIDDLE EAST & AFRICA: INTENSIVE CARE VENTILATORS MARKET,

BY TYPE, 2021–2029 (USD MILLION)         205

TABLE 219            MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)            205

TABLE 220            MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            205

TABLE 221            MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY MODE,

2021–2029 (USD MILLION)            206

TABLE 222            MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            206

TABLE 223            GCC COUNTRIES: VENTILATORS MARKET, BY TYPE, 2021–2029 (USD MILLION)                207

TABLE 224            GCC COUNTRIES: INTENSIVE CARE VENTILATORS MARKET, BY TYPE,

2021–2029 (USD MILLION)            208

TABLE 225            GCC COUNTRIES: VENTILATORS MARKET, BY AGE GROUP,

2021–2029 (USD MILLION)          208

TABLE 226            GCC COUNTRIES: VENTILATORS MARKET, BY INTERFACE,

2021–2029 (USD MILLION)            208

TABLE 227            GCC COUNTRIES: VENTILATORS MARKET, BY MODE, 2021–2029 (USD MILLION)             209

TABLE 228            GCC COUNTRIES: VENTILATORS MARKET, BY CARE SETTING,

2021–2029 (USD MILLION)            209

TABLE 229            OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN

VENTILATORS MARKET, 2021–2025           210

TABLE 230            VENTILATORS MARKET: DEGREE OF COMPETITION 213

TABLE 231            VENTILATORS MARKET: REGION FOOTPRINT                 217

TABLE 232            VENTILATORS MARKET: TYPE FOOTPRINT                 218

TABLE 233            VENTILATORS MARKET: AGE GROUP FOOTPRINT       219

TABLE 234            VENTILATORS MARKET: INTERFACE FOOTPRINT       220

TABLE 235            VENTILATORS MARKET: MODE FOOTPRINT                 221

TABLE 236            VENTILATORS MARKET: CARE SETTING FOOTPRINT       222

TABLE 237            VENTILATORS MARKET: DETAILED LIST OF KEY STARTUPS/SMES              225

TABLE 238            VENTILATORS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES          225

TABLE 239            VENTILATORS MARKET: PRODUCT LAUNCHES & APPROVALS,

JANUARY 2021–JANUARY 2025     229

TABLE 240            VENTILATORS MARKET: DEALS, JANUARY 2021–JANUARY 2025    230

TABLE 241            VENTILATORS MARKET: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025                 231

TABLE 242            RESMED: BUSINESS OVERVIEW 232

TABLE 243            RESMED: PRODUCTS OFFERED 233

TABLE 244            RESMED: PRODUCT LAUNCHES, JANUARY 2021–JANUARY 2025    234

TABLE 245            GETINGE AB: BUSINESS OVERVIEW         235

TABLE 246            GETINGE AB: PRODUCTS OFFERED        236

TABLE 247            GETINGE AB: PRODUCT APPROVALS, JANUARY 2021–JANUARY 2025         237

TABLE 248            GETINGE AB: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     237

TABLE 249            KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW          239

TABLE 250            KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED             240

TABLE 251            KONINKLIJKE PHILIPS N.V.: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     241

TABLE 252            DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW          243

TABLE 253            DRÄGERWERK AG & CO. KGAA: PRODUCTS OFFERED             244

TABLE 254            DRÄGERWERK AG & CO. KGAA: PRODUCT LAUNCHES,

JANUARY 2021–JANUARY 2025     245

TABLE 255            DRÄGERWERK AG & CO. KGAA: DEALS, JANUARY 2021–JANUARY 2025     245

TABLE 256            DRÄGERWERK AG & CO. KGAA: OTHER DEVELOPMENTS,

JANUARY 2021–JANUARY 2025     246

TABLE 257            ICU MEDICAL INC.: BUSINESS OVERVIEW                 247

TABLE 258            ICU MEDICAL, INC.: PRODUCTS OFFERED                 248

TABLE 259            ICU MEDICAL, INC.: DEALS, JANUARY 2021–JANUARY 2025    249

TABLE 260            ASAHI KASEI CORPORATION: BUSINESS OVERVIEW          250

TABLE 261            ASAHI KASEI CORPORATION: PRODUCTS OFFERED             252

TABLE 262            ASAHI KASEI MEDICAL: DEALS, JANUARY 2021–JANUARY 2025    253

TABLE 263            AIR LIQUIDE: BUSINESS OVERVIEW         254

TABLE 264            AIR LIQUIDE: PRODUCTS OFFERED        255

TABLE 265            AIR LIQUIDE: DEALS, JANUARY 2021–JANUARY 2025        256

TABLE 266            FLEXICARE (GROUP) LIMITED: BUSINESS OVERVIEW          257

TABLE 267            FLEXICARE (GROUP) LIMITED: PRODUCTS OFFERED             258

TABLE 268            FLEXICARE (GROUP) LIMITED: DEALS, JANUARY 2021–JANUARY 2025     258

TABLE 269            NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW          259

TABLE 270            NIHON KOHDEN CORPORATION: PRODUCTS OFFERED             260

TABLE 271            NIHON KOHDEN CORPORATION: PRODUCT LAUNCHES,

JANUARY 2021–JANUARY 2025     261

TABLE 272            SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD: BUSINESS OVERVIEW 262

TABLE 273            SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: PRODUCTS OFFERED 263

TABLE 274            GE HEALTHCARE: BUSINESS OVERVIEW                 264

TABLE 275            GE HEALTHCARE: PRODUCTS OFFERED                 265

TABLE 276            GE HEALTHCARE: DEALS, JANUARY 2021–JANUARY 2025    265

TABLE 277            BAXTER: BUSINESS OVERVIEW  266

TABLE 278            BAXTER: PRODUCTS OFFERED 267

TABLE 279            BAXTER: DEALS, JANUARY 2021–JANUARY 2025                 268

TABLE 280            VYAIRE MEDICAL, INC: BUSINESS OVERVIEW                 269

TABLE 281            VYAIRE MEDICAL, INC: PRODUCTS OFFERED                 269

TABLE 282            VYAIRE MEDICAL, INC: DEALS, JANUARY 2021–JANUARY 2025    270

TABLE 283          VYAIRE MEDICAL, INC: OTHER DEVELOPMENTS, JANUARY 2021–JANUARY 2025     270

TABLE 284            HAMILTON MEDICAL: BUSINESS OVERVIEW                 271

TABLE 285            HAMILTON MEDICAL: PRODUCTS OFFERED                 271

TABLE 286            HAMILTON MEDICAL: PRODUCT ENHANCEMENTS, JANUARY 2021-JANUARY 2025                 272

LIST OF FIGURES

FIGURE 1              VENTILATORS MARKET SEGMENTATION                 26

FIGURE 2              RESEARCH DESIGN         31

FIGURE 3              PRIMARY SOURCES         33

FIGURE 4              BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS            35

FIGURE 5              BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION                36

FIGURE 6              BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY CARE SETTING, DESIGNATION, AND REGION                36

FIGURE 7              SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS         37

FIGURE 8              REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V. (NETHERLANDS) (2024)         38

FIGURE 9              SUPPLY-SIDE MARKET SIZE ESTIMATION                 39

FIGURE 10            DEMAND-SIDE MARKET SIZE ESTIMATION                 40

FIGURE 11            CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES FOR VENTILATORS MARKET (2024–2029)               41

FIGURE 12            CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS                 42

FIGURE 13            TOP-DOWN APPROACH                43

FIGURE 14            DATA TRIANGULATION METHODOLOGY                 44

FIGURE 15            VENTILATORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 46

FIGURE 16            VENTILATORS MARKET, BY AGE GROUP, 2024 VS. 2029 (USD MILLION)                47

FIGURE 17           VENTILATORS MARKET, BY INTERFACE, 2024 VS. 2029 (USD MILLION)       47

FIGURE 18            VENTILATORS MARKET, BY MODE, 2024 VS. 2029 (USD MILLION) 48

FIGURE 19            VENTILATORS MARKET, BY CARE SETTING, 2024 VS. 2029 (USD MILLION)      48

FIGURE 20            GEOGRAPHICAL SNAPSHOT OF VENTILATORS MARKET               49

FIGURE 21            RISING PREVALENCE OF CHRONIC RESPIRATORY DISEASES TO DRIVE MARKET       50

FIGURE 22            INTENSIVE CARE VENTILATORS SEGMENT ACCOUNTED FOR

LARGEST SHARE IN 2024                51

FIGURE 23            CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       52

FIGURE 24            NORTH AMERICA WILL DOMINATE THE MARKET TILL 2029           52

FIGURE 25            EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES

OVER FORECAST PERIOD             53

FIGURE 26            VENTILATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,

AND CHALLENGES          54

FIGURE 27            ANNUAL DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION,

BY DISEASE TYPE, 2024  56

FIGURE 28            GLOBAL GERIATRIC POPULATION, BY COUNTRY, 2015–2023      58

FIGURE 29            ACQUISITIONS IN VENTILATORS MARKET, JANUARY 2019–NOVEMBER 2023                 64

FIGURE 30            AVERAGE SELLING PRICE TREND FOR HIGH-END VENTILATORS, BY REGION, 2022–2024 (USD)             70

FIGURE 31            VENTILATORS MARKET: VALUE CHAIN ANALYSIS            72

FIGURE 32            VENTILATORS MARKET: ECOSYSTEM ANALYSIS                 73

FIGURE 33            SUPPLY CHAIN ANALYSIS             75

FIGURE 34            VENTILATORS MARKET: PORTER’S FIVE FORCES ANALYSIS           76

FIGURE 35            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR VENTILATORS     79

FIGURE 36            KEY BUYING CRITERIA FOR VENTILATORS                 80

FIGURE 37            TOP PATENT APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS),

JANUARY 2015–FEBRUARY 2025  87

FIGURE 38            TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES           95

FIGURE 39            NUMBER OF DEALS AND FUNDING IN VENTILATORS MARKET,

2019–2023 (USD MILLION)            96

FIGURE 40            NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023              96

FIGURE 41            VALUE OF INVESTOR DEALS, BY KEY PLAYERS, 2019–2023 (USD MILLION)            97

FIGURE 42            RESPIRATORY DIAGNOSTICS MARKET OVERVIEW          97

FIGURE 43            SLEEP APNEA DEVICES MARKET OVERVIEW                 98

FIGURE 44            AI INTEGRATION FOR VENTILATORS     100

FIGURE 45            IMPACT OF AI/GEN AI ON VENTILATORS MARKET               101

FIGURE 46            NORTH AMERICA: VENTILATORS MARKET SNAPSHOT          141

FIGURE 47            ASIA PACIFIC: VENTILATORS MARKET SNAPSHOT          174

FIGURE 48            REVENUE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2019–2023)         212

FIGURE 49            MARKET SHARE ANALYSIS OF KEY PLAYERS IN VENTILATORS MARKET (2023)   212

FIGURE 50            VENTILATORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023         215

FIGURE 51            VENTILATORS MARKET: COMPANY FOOTPRINT       216

FIGURE 52            VENTILATORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 224

FIGURE 53            R&D EXPENDITURE OF KEY PLAYERS IN VENTILATORS MARKET (2022 VS. 2023)  226

FIGURE 54            EV/EBITDA OF KEY VENDORS   227

FIGURE 55            YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK

BETA OF KEY VENDORS                227

FIGURE 56            BRAND/PRODUCT COMPARATIVE ANALYSIS                 228

FIGURE 57            RESMED: COMPANY SNAPSHOT (2023)   233

FIGURE 58            GETINGE AB: COMPANY SNAPSHOT (2023)                 236

FIGURE 59            KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2023)             240

FIGURE 60            DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2023)             244

FIGURE 61            ICU MEDICAL, INC.: COMPANY SNAPSHOT (2023)    248

FIGURE 62            ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2023)             251

FIGURE 63            AIR LIQUIDE: COMPANY SNAPSHOT (2023)                 255

FIGURE 64            NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)             260

FIGURE 65            SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:

COMPANY SNAPSHOT (2023)      262

FIGURE 66            GE HEALTHCARE: COMPANY SNAPSHOT (2023)                 265

FIGURE 67            BAXTER: COMPANY SNAPSHOT (2023)   267

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧